Shares of Corbus Pharmaceuticals Holdings Inc. /zigman2/quotes/201549545/lastsale CRBP +12.42% rallied 1.69% to $0.42 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.37% rising 3.13% to 13,770.57 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.20% rising 1.65% to 34,725.47. The stock's rise snapped a two-day losing streak. Corbus Pharmaceuticals Holdings Inc. closed $3.58 short of its 52-week high ($4.00), which the company reached on February 11th.
The stock underperformed when compared to some of its competitors Friday, as Fate Therapeutics Inc. /zigman2/quotes/209623007/composite FATE +0.09% rose 2.38% to $36.63, Vanda Pharmaceuticals Inc. /zigman2/quotes/200957783/composite VNDA +1.76% rose 3.08% to $14.74, and Viking Therapeutics Inc. /zigman2/quotes/204618964/composite VKTX -1.44% rose 1.70% to $3.58. Trading volume (1.4 M) eclipsed its 50-day average volume of 986,738.